Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2018.1096
Abstract: Importance For a considerable proportion of pediatric patients, atopic dermatitis symptoms persist into adolescence. Previous studies have focused mainly on (parents of) children, whereas little is known about adolescents with atopic dermatitis. Objective To explore… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2018.4061
Abstract: Importance Knowledge about factors associated with persistence of atopic dermatitis (AD) during childhood is sparse. Objective To explore heritable, environmental, and clinical factors associated with persistent AD based on 13 years’ follow-up of an at-risk… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2019.2983
Abstract: Importance Molecular profiling of skin biopsies is the criterion standard for evaluating the cutaneous atopic dermatitis (AD) phenotype. However, skin biopsies are not always feasible in children. A reproducible minimally invasive approach that can track… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2020.0796
Abstract: Key Points Question What is the relative effectiveness of systemic treatments for patients with atopic dermatitis? Findings This network meta-analysis of 39 randomized clinical trials including 6360 patients found that dupilumab and cyclosporine were similarly… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2021.0009
Abstract: Key Points Question Is atopic dermatitis (AD) associated with lower educational attainment? Findings This nationwide matched cohort study of 61 153 Danish children found evidence of reduced attainment of lower and upper secondary education in… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2021.1450
Abstract: Importance Atopic dermatitis is a common and debilitating skin condition characterized by intense itching and chronic inflammation. Research on behavioral treatments with high accessibility is needed. Objective To investigate the efficacy of a highly scalable… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2021.4529
Abstract: Importance Atopic dermatitis may be associated with short stature and obesity in children, but most previous studies have been either small or cross-sectional. Objective To evaluate the association between atopic dermatitis and height, body mass… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2022.0029
Abstract: This analysis of 2 randomized clinical trials evaluates long-term (52 weeks) efficacy and safety of upadacitinib treatment in patients with atopic dermatitis. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2022.1906
Abstract: Key Points Questions What is the multidimensional burden of atopic dermatitis (AD) in adults, and what is the relative importance of different aspects of disease burden? Findings This survey study included responses from 1065 adult… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2022.2823
Abstract: Importance Photoaggravated atopic dermatitis (PAD) is estimated to affect 1.4% to 16% of patients with AD but remains poorly characterized with limited published data. Objective To provide detailed clinical and photobiological characterization of PAD. Design,… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2022.3488
Abstract: This case series describes the outcomes of COVID-19 and SARS-CoV-2 vaccination in patients with atopic dermatitis who have been treated with tralokinumab. read more here.